CurieAI Launches AI-Driven Platform for COVID-19 Respiratory Monitoring and Management

What You Should Know:

” Actionable information on the disease progression and an early detection of the wear and tear in the condition plays an incredibly crucial role in the treatment of respiratory conditions,” stated Navya Davuluri, Co-Founder and CEO of Curie. “And with our proprietary innovation for respiratory health assessment we allow precisely that and help clinicians make proactive interventions.”.

An essential distinguishing component of CurieAIs platform is its distinct client tracking for allowing early detection of exacerbations accomplished with innovation detection of breathing health biomarkers through monitoring of the patients breathing patterns, captured with basic audio sensors.

Because the start of the pandemic, Curie has actually monitored close to 300 COVID-19 clients. With the existing and brand-new releases, Curie is broadening the offering to assist in the monitoring and management of up to 3,000 COVID-19 clients by the end of the year.

CurieAIs platform has been live for business deployments because early 2020 and is utilized actively by physicians in much better handling a variety of breathing conditions consisting of COPD, Asthma, Fibrosis and more.

Curies system continually monitors the breathing patterns and gives a day-to-day goal assessment of the level of respiratory distress the patient is experiencing. The assessment is personalized to each client and supplied to the doctors with actionable insights on the disease state severity, condition development, and early detection of any wear and tear in the condition..


CurieAI, a Menlo
Park, CA-based health care startup spun-off from SRI
Ventures, the corporate venture arm of SRI International, today revealed
the release of CurieAIs first-of-its-kind AI-driven
platform specifically developed for assisting in the tracking and management
of respiratory conditions surrounding COVID-19. Early releases indicate that
Curies solution could show vital in handling COVID-19 positive patients

With COVID-19 treatment alternatives in limited supply, early detection of degeneration ends up being critical while deciding next steps. Curies service has been shown to be vital in identifying both deterioration in addition to determining stable or enhancing patients..

” We have seen direct correlation with Curie to be able to forecast if a patient is improving or having more severe symptoms,” stated Dr. James Darragh, Chief Medical Officer at SCAHC. “The very first client I specifically remember was a client who had actually currently been treated with Remdesivir and dexamethasone.

The information from the daily objective evaluation, integrated with a safe and secure HIPAA compliant platform, enables proactive interventions to improve patient results while avoiding adverse occasions like emergency situation room gos to and hospitalizations. Curies service has shown strong results in client populations with chronic breathing conditions; an early pilot on moderate to serious asthma population revealed a 90% reduction in ER check outs and hospitalizations.

— SRI Ventures spin-off CurieAI reveals the launch of
its AI-driven COVID-19 case management platform

Milestones to Date.

How It Works.

— The Curie solution has actually been released to monitor
inpatients and outpatients at San Carlos Apache Healthcare Corporation (SCAHC).

In the newest implementation for COVID-19, the Curie solution has actually been adopted to.
display inpatients and outpatients at San Carlos Apache Healthcare Corporation.
( SCAHC). The facility presently serves a population of 20,000 on a booking.
in Peridot, Arizona.